Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Rena
Chim C Lang

Circulation

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Circulation|January 23, 2003
Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failureDonna M Mancini, Stuart D Katz, Chim C Lang, et al.
Circulation|January 23, 2003
Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockersTimothy J Vittorio, Chim C Lang, Stuart D Katz, et al.
Circulation|September 1, 2020
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF TrialNatalie A Mordi, Ify R Mordi, Jagdeep S Singh, et al.
Circulation|February 16, 2006
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) ProgramEileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
Circulation|July 14, 2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant DataBakhtawar K Mahmoodi, Vinicius Tragante, Marcus E Kleber, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Circulation|January 23, 2003
Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failureDonna M Mancini, Stuart D Katz, Chim C Lang, et al.
Circulation|January 23, 2003
Vasopressor response to angiotensin II infusion in patients with chronic heart failure receiving beta-blockersTimothy J Vittorio, Chim C Lang, Stuart D Katz, et al.
Circulation|September 1, 2020
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF TrialNatalie A Mordi, Ify R Mordi, Jagdeep S Singh, et al.
Circulation|February 16, 2006
Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) ProgramEileen O'Meara, Tim Clayton, Margaret B McEntegart, et al.
Circulation|July 14, 2020
Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant DataBakhtawar K Mahmoodi, Vinicius Tragante, Marcus E Kleber, et al.
Pageof 1